Triterpene derivatives that block entry of human immunodeficiency virus type 1 into cells.

A series of triterpene compounds characterized by a stringent structure-activity relationship were identified as potent and selective inhibitors of human immunodeficiency virus type 1 (HIV-1) replication. Currently studied botulinic derivatives have 50% inhibitory concentrations (IC50) against HIV-1...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Mayaux, J F, Bousseau, A, Pauwels, R, Huet, T, Hénin, Y, Dereu, N, Evers, M, Soler, F, Poujade, C, De Clercq, E
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 1994
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC43620/
https://ncbi.nlm.nih.gov/pubmed/8170948
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak